Thanhvien Tran
Amgen (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Receptor Mechanisms and Signaling, Pancreatic function and diabetes, GDF15 and Related Biomarkers, Nuclear Receptors and Signaling
Most-Cited Works
- → Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy(2005)536 cited
- → Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys(2017)227 cited
- → A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents(2012)136 cited
- → AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents(2011)94 cited
- → GDF15 deficiency promotes high fat diet-induced obesity in mice(2018)91 cited
- → Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles(2013)81 cited
- → Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists(2014)24 cited
- → C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators(2014)15 cited